OCUL Stock Summary and Trading Ideas (Ocular Therapeutix | NASDAQ:OCUL)

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

What symbol and exchange does Ocular Therapeutix shares trade?

Ocular Therapeutix trades on the NASDAQ stock market under the symbol OCUL.

What is Ocular Therapeutix stock price doing today?

As of August 12, 2026, OCUL stock price climbed to $10.23 with 3,784,011 million shares trading.

What is Ocular Therapeutix's Beta?

OCUL has a beta of 1.12, meaning it tends to be more sensitive to market movements. OCUL has a correlation of 0.06 to the broad based SPY ETF.

How much is Ocular Therapeutix worth?

OCUL has a market cap of $2.25 billion. This is considered a Mid Cap stock.

How much money does Ocular Therapeutix make?

Last quarter Ocular Therapeutix reported $13 million in Revenue and -$.35 earnings per share. This beat revenue expectation by $379,040 and exceeded earnings estimates by $.04.

What is the highest and lowest price Ocular Therapeutix traded in the last 3 year period?

In the last 3 years, OCUL traded as high as $16.44 and as low as $2.00.

What are the top ETFs holding Ocular Therapeutix?

The top ETF exchange traded funds that OCUL belongs to (by Net Assets): VTI, IWM, VXF, PJP, IWO.

Is Ocular Therapeutix (OCUL) a good investment?

OCUL has underperformed the market in the last year with a return of -18.6%, while SPY returned +22.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OCUL shares. However, OCUL has outperformed the market in the last 3 month and 2 week periods, returning +10.2% and +21.1%, while SPY returned +4.7% and +4.3%, respectively. This indicates OCUL has been having a stronger performance recently.

What are the support and resistance levels for Ocular Therapeutix (OCUL)?

OCUL support price is $9.45 and resistance is $10.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OCUL shares will trade within this expected range on the day.